Registration for a live webinar on 'Chronic inflammation, immune cell trafficking and anti-trafficking agents' is now open.See webinar details
Dr. Birgit Schoeberl Merrimack Pharmaceuticals, USA1 Talk
Birgit Schoeberl, Ph.D. serves as Merrimack’s Head of Discovery. She is responsible for Merrimack’s products from idea stage to Phase 2 clinical Proof-of-Concept. Prior to her current role she implemented Systems Biology into the Merrimack drug discovery and development process by building the Merrimack Drug Discovery Engine, the “PODs”, and... read moreserving as MM-121 project leader. Prior to joining Merrimack, Dr. Schoeberl was a post-doctoral fellow at the Massachusetts Institute of Technology, where she built some of the earliest computational models of signaling networks. Dr. Schoeberl holds a Ph.D. in systems biology from the Max Planck Institute for Dynamics of Complex Technical Systems in Germany and an M.S. in chemical engineering from the University of Karlsruhe in Germany.